US Stock MarketDetailed Quotes

ABBV AbbVie

Watchlist
  • 192.870
  • -0.580-0.30%
Close Feb 14 16:00 ET
  • 192.870
  • 0.0000.00%
Post 20:01 ET
340.48BMarket Cap80.70P/E (TTM)

About AbbVie Company

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Company Profile

SymbolABBV
Company NameAbbVie
Listing DateDec 10, 2012
Founded2011
CEOMr. Robert A. Michael
MarketNYSE
Employees55000
Fiscal Year Ends12-31
Address1 North Waukegan Road
CityNorth Chicago
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-847-932-7900

Company Executives

  • Name
  • Position
  • Salary
  • Robert A. Michael
  • Director and Chief Executive Officer
  • 14.44M
  • Timothy J. Richmond
  • Executive Vice President and Chief Human Resources Officer
  • --
  • Dr. Roopal Thakkar, M.D.
  • Executive Vice President, Research and Development and Chief Scientific Officer
  • --
  • Dr. Nicholas Donoghoe, M.D.
  • Executive Vice President, Chief Business and Strategy Officer
  • --
  • Jeffrey Ryan Stewart
  • Executive Vice President and Chief Commercial Officer
  • 15.35M
  • Scott Reents
  • Executive Vice President and Chief Financial Officer
  • 10.19M
  • Dr. Azita Saleki-Gerhardt, B.S.,M.S.,PhD
  • Executive Vice President and Chief Operations Officer
  • 9.30M
  • Kevin K. Buckbee
  • Senior Vice President, Controller and Principal Accounting Officer
  • --
  • Perry C. Siatis
  • Executive Vice President, General Counsel and Secretary
  • --
  • Richard A. Gonzalez
  • Chairman of the Board
  • 25.66M
  • Frederick H. Waddell
  • Independent Director
  • 369.98K
  • Edward J. Rapp
  • Independent Director
  • 394.98K
  • Dr. Susan E. Quaggin, M.D.
  • Independent Director
  • 24.00K
  • Roxanne S. Austin
  • Lead Independent Director
  • 388.39K
  • Jennifer L. Davis
  • Independent Director
  • 45.00K
  • Rebecca B. Roberts
  • Independent Director
  • 359.98K
  • Thomas C. Freyman
  • Independent Director
  • 389.98K
  • William H.L. Burnside
  • Independent Director
  • 377.48K
  • Brett J. Hart
  • Independent Director
  • 384.98K
  • Melody B. Meyer
  • Independent Director
  • 369.98K
  • Glenn F. Tilton
  • Independent Director
  • 421.58K
  • Dr. Robert J. Alpern,M.D.
  • Independent Director
  • 461.18K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More